Health Insurers Make Money by Estimating Next Year Correctly
Premiums are set in advance for care that has not happened. The business is a forecasting exercise where the regulator caps how much of the premium can be kept.
The Core Mechanic
An insurer sets a premium for the coming year based on expected medical costs for the covered population, then pays whatever those costs turn out to be.
Getting the estimate wrong in one direction produces losses. Getting it wrong in the other produces excess profit that regulation frequently requires to be returned.
The central operational metric is the medical loss ratio: medical costs as a percentage of premium. The remainder covers administration, taxes, and profit.
In several regulated markets the loss ratio has a floor. Spend less than the required proportion on care and the difference is rebated to customers, which caps the upside from underpaying for care.
The Consequence of the Cap
If the retained share is capped as a percentage of premium, then the absolute amount retained grows only if premium grows.
That creates an incentive structure worth stating plainly: an insurer earning a fixed percentage of a larger number benefits from the number being larger. It is a genuine criticism of percentage based caps and it applies regardless of intent.
The countervailing pressure is competition. An insurer whose premiums rise faster than rivals loses members, and members are the base the percentage applies to.
Where Insurers Actually Compete
| Lever | Effect |
|---|---|
| Provider network negotiation | The largest determinant of cost |
| Utilisation management | Controls cost, generates disputes |
| Risk selection and pricing | Constrained by regulation |
| Administrative efficiency | Small share of total |
| Care management | Reduces cost by improving outcomes |
Network negotiation is the main one. An insurer with many members has leverage over providers, and a provider system with local dominance has leverage over insurers. The resulting negotiation determines what care costs, and consolidation on both sides has been the defining industry trend.
Utilisation management, meaning prior authorisation and coverage determinations, is where the sector generates most of its public conflict. It controls cost and it places the insurer between a patient and a treatment their clinician recommended.
Risk Adjustment
In regulated markets where insurers cannot decline applicants or price on health status, they would otherwise have a strong incentive to attract healthy members and avoid sick ones.
Risk adjustment transfers money between insurers based on the assessed health status of their members, so that enrolling sicker members is not financially punitive.
The system depends on documented diagnoses, which creates its own incentive: more thorough documentation of member conditions increases risk adjusted payments. This has been the subject of substantial regulatory scrutiny, since the line between accurate documentation and revenue driven coding is genuinely difficult to draw.
Vertical Integration
Large insurers have acquired pharmacy benefit managers, clinics, and care delivery businesses.
The stated rationale is coordinating care and controlling cost across the chain rather than only at the insurance layer. The financial effect is that medical spending paid to an owned subsidiary counts as medical cost for loss ratio purposes while the profit is retained within the group.
Both readings are accurate simultaneously, which is why the structure attracts attention.
The Bottom Line
Health insurers price a year ahead for costs that arrive later, under rules capping the retained share of premium. That cap limits margin percentage and rewards premium growth, which is a structural criticism worth understanding. Competition runs primarily through provider network negotiation, utilisation management generates the disputes, and vertical integration lets medical spending and retained profit sit inside the same group.